Get notified when CAVA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: CAVA CAVA GROUP, INC. 10-Q

CAVA Q2 FY26: revenue $368.4M, net income $23.0M. Revenue +31%, same-store sales +9%, but cyclosporiasis outbreak hits Q3

Filed August 12, 2026 · Period ending July 12, 2026 · Compared to 10-Q Aug 13, 2025 · ~2 min read

Key Changes

  • high

    Revenue rose 31.3% to $368.4M in Q2 FY26, driven by 9.0% same-restaurant sales growth (5.3% traffic, 3.7% price/mix) and 78 net new restaurants over the trailing twelve months. Operating income increased 37% to $26.8M.

    MD&A: Financial Results verify on EDGAR →
  • high

    A multistate cyclosporiasis outbreak linked to iceberg lettuce has adversely impacted Q3 FY26 revenue despite no CAVA ingredients being implicated. The company notes the impact is moderating but duration remains uncertain.

    MD&A: Cyclosporiasis Outbreak verify on EDGAR →
  • medium

    Digital revenue mix reached 39.0% in Q2 FY26 (up from 37.3% prior year), with higher third-party delivery driving other operating expenses to 12.8% of revenue from 12.4%.

    MD&A: Digital & Delivery verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.

Partner

Trade CAVA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 13, 2026 · How we verify